Works by Scher, H I

Results: 29

Intracavitary birdcage resonator: applications to the human prostate.

Published in:

1995

By:

Merchant, Thomas E.;
Schwartz, Lawrence H.;
Ballon, Douglas;
Koutcher, Jason A.;
Scher, Howard I.;
Minsky, Bruce D.;
Merchant, T E;
Schwartz, L H;
Ballon, D;
Koutcher, J A;
Scher, H I;
Minsky, B D

Publication type:

journal article

Management of prostate cancer after prostatectomy: treating the patient, not the PSA.

Published in:

1999

By:

Scher, H I

Publication type:

commentary

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

Published in:

British Journal of Cancer, 2013, v. 109, n. 10, p. 2579, doi. 10.1038/bjc.2013.619

By:

Bianchini, D;
Omlin, A;
Pezaro, C;
Lorente, D;
Ferraldeschi, R;
Mukherji, D;
Crespo, M;
Figueiredo, I;
Miranda, S;
Riisnaes, R;
Zivi, A;
Buchbinder, A;
Rathkopf, D E;
Attard, G;
Scher, H I;
de Bono, J;
Danila, D C

Publication type:

Article

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.

Published in:

1991

By:

Seidman, Andrew D.;
Scher, Howard I.;
Heinemann, M. H.;
Bajorin, Dean F.;
Sternberg, Cora N.;
Dershaw, D. David;
Silverberg, Mary;
Bosl, George J.;
Seidman, A D;
Scher, H I;
Bajorin, D F;
Sternberg, C N;
Dershaw, D D;
Silverberg, M;
Bosl, G J

Publication type:

journal article

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.

Published in:

1990

By:

Motzer, Robert J.;
Cooper, Karen;
Geller, Nancy L.;
Pfister, David G.;
Lin, Shiow-Yun;
Bajorin, Dean;
Scher, Howard I.;
Herr, Harry;
Fair, William;
Morse, Michael;
Sogani, Pramod;
Whitmore, Willet;
Bosl, George J.;
Motzer, R J;
Cooper, K;
Geller, N L;
Pfister, D G;
Lin, S Y;
Bajorin, D;
Scher, H I

Publication type:

journal article

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

Published in:

1989

By:

Sternberg, Cora N.;
Yagoda, Alan;
Scher, Howard I.;
Watson, Robin C.;
Geller, Nancy;
Herr, Harry W.;
Morse, Michael J.;
Sogani, Pramod C.;
Vaughan, E. Darracott;
Bander, Neil;
Weiselberg, Lora;
Rosado, Kim;
Smart, Tracy;
Lin, Shiow-Yun;
Penenberg, Darryl;
Fair, William R.;
Whitmore, Willet F.;
Sternberg, C N;
Yagoda, A;
Scher, H I

Publication type:

journal article

Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamide.

Published in:

1984

By:

Ahmed, Tauseef;
Benedetto, Pasquale;
Yagoda, Alan;
Watson, Robin C.;
Scher, Howard I.;
Herr, Harry W.;
Sogani, Pramod C.;
Whitmore, Willet F.;
Pertschuk, Louis;
Ahmed, T;
Benedetto, P;
Yagoda, A;
Watson, R C;
Scher, H I;
Herr, H W;
Sogani, P C;
Whitmore, W F;
Pertschuk, L

Publication type:

journal article

Suramin: here to stay!?

Published in:

1993

By:

Scher, Howard I.;
Scher, H I

Publication type:

commentary

Androgen dynamics and serum PSA in patients treated with abiraterone acetate.

Published in:

Prostate Cancer & Prostatic Diseases, 2014, v. 17, n. 2, p. 192, doi. 10.1038/pcan.2014.8

By:

Ryan, C J;
Peng, W;
Kheoh, T;
Welkowsky, E;
Haqq, C M;
Chandler, D W;
Scher, H I;
Molina, A

Publication type:

Article

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2014, v. 17, n. 1, p. 34, doi. 10.1038/pcan.2013.41

By:

Goodman, O B;
Flaig, T W;
Molina, A;
Mulders, P F A;
Fizazi, K;
Suttmann, H;
Li, J;
Kheoh, T;
de Bono, J S;
Scher, H I

Publication type:

Article

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy.

Published in:

Prostate Cancer & Prostatic Diseases, 2004, v. 7, n. 1, p. 63, doi. 10.1038/sj.pcan.4500694

By:

Orange, D. E.;
Jegathesan, M.;
Blachère, N. E.;
Frank, M. O.;
Scher, H. I.;
Albert, M. L.;
Darnell, R. B.

Publication type:

Article

Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2001, v. 4, n. 1, p. 33, doi. 10.1038/sj.pcan.4500491

By:

Sepp-Lorenzino, L;
Tjaden, G;
Moasser, M M;
Timaul, N;
Ma, Z;
Kohl, N E;
Gibbs, J B;
Oliff, A;
Rosen, N;
Scher, H I

Publication type:

Article

The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cells.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 1, p. 41, doi. 10.1038/sj.pcan.4500282

By:

Sepp-Lorenzino, L;
Balog, A;
Su, D-S;
Meng, D;
Timaul, N;
Scher, H I;
Danishefsky, S J;
Rosen, N

Publication type:

Article

Novel strategies and therapeutics for the treatment of prostate carcinoma.

Published in:

2000

By:

Morris, Michael J.;
Scher, Howard I.;
Morris, M J;
Scher, H I

Publication type:

journal article

Identification and characterization of circulating prostate carcinoma cells.

Published in:

2000

By:

Wang, Zheng-Pin;
Eisenberger, Mario A.;
Carducci, Michael A.;
Partin, Alan W.;
Scher, Howard I.;
Ts'o, Paul O. P.;
Wang, Z P;
Eisenberger, M A;
Carducci, M A;
Partin, A W;
Scher, H I;
Ts'o, P O

Publication type:

journal article

Detectable tumor cells in the blood and bone marrow: smoke or fire?

Published in:

1998

By:

Slovin, Susan F.;
Scher, Howard I.;
Slovin, S F;
Scher, H I

Publication type:

commentary

Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study.

Published in:

1998

By:

Roth, Andrew J.;
Kornblith, Alice B.;
Batel-Copel, Laure;
Peabody, Elizabeth;
Scher, Howard I.;
Holland, Jimmie C.;
Roth, A J;
Kornblith, A B;
Batel-Copel, L;
Peabody, E;
Scher, H I;
Holland, J C

Publication type:

journal article

Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care.

Published in:

1994

By:

Kornblith, Alice B.;
Herr, Harry W.;
Ofman, Ursula S.;
Scher, Howard I.;
Holland, Jimmie C.;
Kornblith, A B;
Herr, H W;
Ofman, U S;
Scher, H I;
Holland, J C

Publication type:

journal article

Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial.

Published in:

1993

By:

Motzer, Robert J.;
Dmitrovsky, Ethan;
Miller, Wilson H.;
Tong, William P.;
Bajorin, Dean F.;
Scher, Howard I.;
Bosl, George J.;
Motzer, R J;
Dmitrovsky, E;
Miller, W H Jr;
Tong, W P;
Bajorin, D F;
Scher, H I;
Bost, G J

Publication type:

journal article

Immune-mediated thrombocytopenia secondary to suramin.

Published in:

1993

By:

Seidman, Andrew D.;
Schwartz, Michael;
Reich, Lillian;
Scher, Howard I.;
Seidman, A D;
Schwartz, M;
Reich, L;
Scher, H I

Publication type:

journal article

Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapy.

Published in:

1992

By:

Petrylak, D P;
Scher, H I;
Li, Z;
Myers, C E;
Geller, N L

Publication type:

journal article

Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity.

Published in:

1992

By:

Conti, John A.;
Scher, Howard I.;
Conti, J A;
Scher, H I

Publication type:

journal article

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy.

Published in:

1992

By:

Zelefsky, Michael J.;
Scher, Howard I.;
Krol, George;
Portenoy, Russell K.;
Leibel, Steven A.;
Fuks, Zvi Y.;
Zelefsky, M J;
Scher, H I;
Krol, G;
Portenoy, R K;
Leibel, S A;
Fuks, Z Y

Publication type:

journal article

Phase I/Il Study of MDV3 100 in Patients With Progressive Castration-Resistant Prostate Cancer.

Published in:

2008

By:

Scher, H. I.;
Beer, T. M.;
Higano, C. S.

Publication type:

Abstract

HER2 in prostate cancer--a viable target or innocent bystander?

Published in:

2000

By:

Scher, Howard I.;
Scher, H I

Publication type:

Editorial

Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence.

Published in:

1999

By:

Agus, David B.;
Cordon-Cardo, Carlos;
Agus, D B;
Cordon-Cardo, C;
Fox, W;
Drobnjak, M;
Koff, A;
Golde, D W;
Scher, H I

Publication type:

journal article

Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer.

Published in:

1999

By:

Scher, Howard I.;
Kelly, W. M. Kevin;
Zhang, Zuo-Feng;
Ouyang, Peter;
Sun, Min;
Schwartz, Morton;
Ding, Cliff;
Wang, Weiping;
Horak, Ivan D.;
Kremer, Alton B.;
Scher, H I;
Kelly, W M;
Zhang, Z F;
Ouyang, P;
Sun, M;
Schwartz, M;
Ding, C;
Wang, W;
Horak, I D;
Kremer, A B

Publication type:

journal article

Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.

Published in:

1998

By:

Cordon-Cardo, Carlos;
Koff, Andrew;
Cordon-Cardo, C;
Koff, A;
Drobnjak, M;
Capodieci, P;
Osman, I;
Millard, S S;
Gaudin, P B;
Fazzari, M;
Zhang, Z F;
Massague, J;
Scher, H I

Publication type:

journal article

ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression.

Published in:

Oncogene, 2006, v. 25, n. 39, p. 5462, doi. 10.1038/sj.onc.1209536

By:

Peduto, L.;
Reuter, V. E.;
Sehara-Fujisawa, A.;
Shaffer, D. R.;
Scher, H. I.;
Blobel, C. P.

Publication type:

Article